Maina P. Kava is a Pediatric Neurologist based in Perth, WA, Australia.
In many cases, families come in because something is worrying them about how a child’s brain, nerves, or muscles are working. That might be ongoing seizures, periods of unusual behaviour, or problems with movement and muscle control. Maina also looks after children who have rare neurological and metabolic conditions, where early support and clear day-to-day plans really matter.
The focus is on gentle, practical care for kids, and good communication with parents and carers. Over time, that helps families make sense of symptoms, understand what to watch for, and feel more confident about next steps. Neurology can be stressful. So the appointments are kept calm and straightforward, with time to answer questions.
Care may include conditions such as epilepsy and seizures in children, and symptoms like spasticity. Maina also supports children and families affected by muscle disorders, including Duchenne muscular dystrophy and Becker muscular dystrophy. At times, there are also concerns around cramps or muscle twitching, such as cramp-fasciculation syndrome. For some children, the nervous system issues link to genetic or metabolic problems, including glycine encephalopathy, Leigh syndrome, cytochrome c oxidase deficiency, pyridoxine (vitamin B6) deficiency, and related disorders like porphyria and protoporphyria.
Because some of these conditions can be complex, care often involves thinking about the whole picture. That might include how symptoms change over time, how to manage flare-ups, and how treatment plans fit with school, sleep, and daily routines. Maina aims to help families stay organised and prepared, not just during clinic visits, but between them too.
If a child needs tests or ongoing monitoring, the approach is to make each stage easier to follow. The goal is simple: support the child’s health and comfort, while giving parents and carers clear, honest guidance.
Maina P. Kava works in Perth and helps families across WA who are dealing with childhood neurological and muscle conditions. In the right cases, discussions may also include how new evidence could guide care, including clinical trial options where they are relevant and available.
